These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30377436)

  • 21. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.
    Micic D; Sumarac-Dumanovic M; Kendereski A; Cvijovic G; Zoric S; Pejkovic D; Micic J; Milic N; Dieguez C; Casanueva FF
    J Endocrinol Invest; 2007 Nov; 30(10):820-7. PubMed ID: 18075283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
    Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens.
    Tosi F; Villani M; Migazzi M; Faccin G; Garofalo S; Fiers T; Kaufman JM; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3414-e3425. PubMed ID: 34050757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.
    Romualdi D; Versace V; Tagliaferri V; De Cicco S; Immediata V; Apa R; Guido M; Lanzone A
    J Endocrinol Invest; 2019 Sep; 42(9):1089-1097. PubMed ID: 30847861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
    Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
    Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.
    Amato MC; Vesco R; Vigneri E; Ciresi A; Giordano C
    J Endocrinol Invest; 2015 Dec; 38(12):1319-26. PubMed ID: 26294351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity in women with polycystic ovary syndrome.
    Vrbíková J; Cibula D; Dvoráková K; Stanická S; Sindelka G; Hill M; Fanta M; Vondra K; Skrha J
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2942-5. PubMed ID: 15181081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.